PATENT CLAIM ANALYSIS

Application Number: 16058684
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["514", "211090"]

Abstract:
The present invention relates to novel crystalline forms of compound (I), (3-Amino-oxetan-3-ylmethyl)-[2-(5,5-dioxo-5,6,7,9-tetrahydro-5lambda*6*-thia-8-aza-benzocyclohepten-8-yl)-6-methyl-quinazolin-4-yl]-amine and pharmaceutical compositions comprising the crystalline forms thereof disclosed herein, which may be used for the treatment or prophylaxis of a viral disease in a patient relating to respiratory syncytial virus (RSV) infection or a disease caused by RSV infection.

Claim (Index 6):
A crystalline form according to  claim 1 , wherein the crystalline form is Form B that exhibits an X-ray powder diffraction (XRPD) pattern with characteristic peaks expressed in degrees 2-theta at 10.21\u00b0\u00b10.10\u00b0, 11.93\u00b0\u00b10.10\u00b0, 13.22\u00b0\u00b10.10\u00b0, 14.35\u00b0\u00b10.10\u00b0, 18.56\u00b0\u00b10.10\u00b0, 20.79\u00b0\u00b10.10\u00b0, 23.24\u00b0\u00b10.10\u00b0 and 25.15\u00b0\u00b10.10\u00b0.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 96.0
- Lexical Diversity: 1.34545
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15870151', '15820241', '15186415', '13908949', '14009589']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7348854671661
- 35 USC 102 Novelty (BERT): 0.6440341577564569
- Combined Prediction Score: 0.7258003362251357
- Mean Citation Score: 429.195338
- Max Citation Score: 598.18317
- Similarity Product: 567.5792052180503

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test